MX2019009573A - Combinaciones de lisobactina y aminoglucosidos contra enfermedades causadas por bacterias gram positivas y gram negativas en animales no humanos. - Google Patents
Combinaciones de lisobactina y aminoglucosidos contra enfermedades causadas por bacterias gram positivas y gram negativas en animales no humanos.Info
- Publication number
- MX2019009573A MX2019009573A MX2019009573A MX2019009573A MX2019009573A MX 2019009573 A MX2019009573 A MX 2019009573A MX 2019009573 A MX2019009573 A MX 2019009573A MX 2019009573 A MX2019009573 A MX 2019009573A MX 2019009573 A MX2019009573 A MX 2019009573A
- Authority
- MX
- Mexico
- Prior art keywords
- gram
- human animals
- lysobactin
- positive
- negative bacteria
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/15—Depsipeptides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se refiere a la combinación de lisobactina con un antibiótico aminoglucósido para su uso en el tratamiento de enfermedades causadas por bacterias gram positivas y Gram negativas en animales no humanos. Se ha comprobado que la invención es particularmente útil con relación al tratamiento de mastitis en animales no humanos. Particularmente la presente invención puede tratar la mastitis bovina.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17156737.3A EP3363452A1 (en) | 2017-02-17 | 2017-02-17 | Combinations of lysobactin and aminogylcosides against diseases caused by gram-positive and gram-negative bacteria in non-human animals |
PCT/EP2018/053667 WO2018149871A1 (en) | 2017-02-17 | 2018-02-14 | Combinations of lysobactin and aminoglycosides against diseases caused by gram-positive and gram-negative bacteria in non-human animals |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2019009573A true MX2019009573A (es) | 2019-10-02 |
Family
ID=58098497
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2019009573A MX2019009573A (es) | 2017-02-17 | 2018-02-14 | Combinaciones de lisobactina y aminoglucosidos contra enfermedades causadas por bacterias gram positivas y gram negativas en animales no humanos. |
Country Status (16)
Country | Link |
---|---|
US (2) | US20200230204A1 (es) |
EP (2) | EP3363452A1 (es) |
JP (1) | JP6655771B1 (es) |
KR (1) | KR102123599B1 (es) |
CN (1) | CN110234338A (es) |
AR (1) | AR111569A1 (es) |
AU (1) | AU2018222615B2 (es) |
BR (1) | BR112019017010A2 (es) |
CA (1) | CA3053608C (es) |
ES (1) | ES2893927T3 (es) |
MX (1) | MX2019009573A (es) |
NZ (1) | NZ755710A (es) |
RU (1) | RU2760008C2 (es) |
TW (1) | TWI783969B (es) |
UY (1) | UY37607A (es) |
WO (1) | WO2018149871A1 (es) |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4011312A (en) * | 1975-06-25 | 1977-03-08 | American Home Products Corporation | Prolonged release drug form for the treatment of bovine mastitis |
US4172138A (en) * | 1977-03-23 | 1979-10-23 | Rhodes Russell E | Method and composition of matter for the treatment of dry cows for mastitis |
CA1266247C (en) | 1985-03-25 | 1990-02-27 | ANTIBIOTIC PREPARED BY LYSOBACTER SP. SC14.067 | |
JPH01132600A (ja) | 1987-11-17 | 1989-05-25 | Shionogi & Co Ltd | カタノシンaおよびbならびにその製造法 |
DE10320781A1 (de) | 2003-05-09 | 2004-11-25 | Bayer Healthcare Ag | Acylierte Nonadepsipeptide |
US20050191270A1 (en) * | 2004-02-27 | 2005-09-01 | Hydromer, Inc. | Anti-infectious hydrogel compositions |
DE102004051025A1 (de) | 2004-10-20 | 2006-04-27 | Bayer Healthcare Ag | Substituierte Nonadepsipeptide |
DE102004051024A1 (de) | 2004-10-20 | 2006-04-27 | Bayer Healthcare Ag | Heterocyclyl-substituierte Nonadepsipeptide |
DE102004051023A1 (de) * | 2004-10-20 | 2006-05-04 | Bayer Healthcare Ag | Desoxo-Nonadepsipeptide |
DE102004053407A1 (de) * | 2004-11-05 | 2006-05-11 | Bayer Healthcare Ag | Acylierte Nonadepsipeptide II |
DE102004053409A1 (de) | 2004-11-05 | 2006-05-11 | Bayer Healthcare Ag | Verfahren zur gezielten Herstellung von Lysobactinfragmenten |
DE102004053410A1 (de) | 2004-11-05 | 2006-05-11 | Bayer Healthcare Ag | Cyclische Nonadepsipeptidamide |
DE102006003443A1 (de) | 2006-01-25 | 2007-07-26 | Aicuris Gmbh & Co. Kg | Asparagin-10-substituierte Nonadepsipeptide |
DE102006018080A1 (de) | 2006-04-13 | 2007-10-18 | Aicuris Gmbh & Co. Kg | Lysobactinamide |
DE102006018250A1 (de) | 2006-04-13 | 2007-10-18 | Aicuris Gmbh & Co. Kg | Verfahren zum Herstellen von cyclischen Depsipeptiden |
CA2890933C (en) * | 2012-12-03 | 2021-06-08 | Novobiotic Pharmaceuticals, Llc | Novel depsipeptide and uses thereof |
-
2017
- 2017-02-17 EP EP17156737.3A patent/EP3363452A1/en not_active Withdrawn
-
2018
- 2018-02-09 TW TW107104733A patent/TWI783969B/zh active
- 2018-02-14 CN CN201880009227.9A patent/CN110234338A/zh active Pending
- 2018-02-14 KR KR1020197023257A patent/KR102123599B1/ko active IP Right Grant
- 2018-02-14 RU RU2019129026A patent/RU2760008C2/ru active
- 2018-02-14 CA CA3053608A patent/CA3053608C/en active Active
- 2018-02-14 MX MX2019009573A patent/MX2019009573A/es unknown
- 2018-02-14 EP EP18704560.4A patent/EP3548059B1/en active Active
- 2018-02-14 NZ NZ755710A patent/NZ755710A/en unknown
- 2018-02-14 BR BR112019017010A patent/BR112019017010A2/pt unknown
- 2018-02-14 ES ES18704560T patent/ES2893927T3/es active Active
- 2018-02-14 AU AU2018222615A patent/AU2018222615B2/en active Active
- 2018-02-14 JP JP2019544033A patent/JP6655771B1/ja active Active
- 2018-02-14 US US16/486,724 patent/US20200230204A1/en not_active Abandoned
- 2018-02-14 WO PCT/EP2018/053667 patent/WO2018149871A1/en unknown
- 2018-02-16 UY UY0001037607A patent/UY37607A/es not_active Application Discontinuation
- 2018-02-16 AR ARP180100377A patent/AR111569A1/es unknown
-
2021
- 2021-09-03 US US17/466,863 patent/US20220000969A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
KR102123599B1 (ko) | 2020-06-16 |
WO2018149871A1 (en) | 2018-08-23 |
AU2018222615A1 (en) | 2019-08-08 |
CA3053608C (en) | 2020-09-15 |
EP3548059A1 (en) | 2019-10-09 |
TW201834662A (zh) | 2018-10-01 |
RU2019129026A (ru) | 2021-03-17 |
CA3053608A1 (en) | 2018-08-23 |
KR20190097293A (ko) | 2019-08-20 |
JP6655771B1 (ja) | 2020-02-26 |
RU2019129026A3 (es) | 2021-03-17 |
US20200230204A1 (en) | 2020-07-23 |
EP3363452A1 (en) | 2018-08-22 |
RU2760008C2 (ru) | 2021-11-22 |
AU2018222615B2 (en) | 2020-07-23 |
ES2893927T3 (es) | 2022-02-10 |
NZ755710A (en) | 2022-04-29 |
US20220000969A1 (en) | 2022-01-06 |
BR112019017010A2 (pt) | 2020-04-14 |
AR111569A1 (es) | 2019-07-31 |
EP3548059B1 (en) | 2021-07-21 |
CN110234338A (zh) | 2019-09-13 |
JP2020508299A (ja) | 2020-03-19 |
UY37607A (es) | 2018-09-28 |
TWI783969B (zh) | 2022-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018001075A (es) | Agentes terapeuticos y profilacticos antibacterianos. | |
MX2022006525A (es) | Activo de polipeptidos de lisina contra bacterias gram-negativas. | |
PE20191356A1 (es) | Suministro de proteinas basado en bacterias con virulencia atenuada | |
PH12016501512A1 (en) | Treatment for resistant acne | |
PH12016501577A1 (en) | Monobactam organic compounds for the treatment of bacterial infections | |
BR112018009235A2 (pt) | composição de aditivo alimentar | |
CL2017002176A1 (es) | Identificación bacteriana y prueba de susceptibilidad antimicrobiana. | |
PH12019500360A1 (en) | Antibiotic compounds | |
PH12015502216A1 (en) | Compositions and methods for improving the health of aquatic animals | |
MX2019007613A (es) | Terapia de combinacion con compuestos ?-lactamicos sustituidos con amidina e inhibidores de ?-lactamasa para infecciones con cepas bacterianas resistentes a antibioticos. | |
NZ724798A (en) | Polymyxin derivatives as antimicrobial compounds | |
WO2017218922A3 (en) | Compositions and methods for the treatment of bacterial infections | |
MX2017009094A (es) | Derivado de polimixina y usos del mismo. | |
WO2016108930A3 (en) | Antisense antibacterial compounds and methods | |
BR112018014175A2 (pt) | composição antibacteriana e método para tratar infecções estafilocócicas com a composição antibacteriana | |
MX2016010385A (es) | Agentes antibacterianos. | |
PH12016501532A1 (en) | Antibacterial combinations comprising polymyxin | |
PH12014501239A1 (en) | Thymol and totarol antibacterial composition | |
PH12019500331A1 (en) | Beta-lactamase inhibitors | |
MX2019009573A (es) | Combinaciones de lisobactina y aminoglucosidos contra enfermedades causadas por bacterias gram positivas y gram negativas en animales no humanos. | |
BR112016030962A2 (pt) | uso de inibidores de metaloproteinase contra infecções bacterianas | |
CO2019006311A2 (es) | N-acetilcisteína para su uso como agente antibacteriano | |
MX2023012943A (es) | Compuesto antibacteriano. | |
EP3873917A4 (en) | COMPOSITIONS AND METHODS COMPRISING LYSOCINES AS BIOTECHNICAL ANTIMICROBIAL FOR USE IN TARGETING GRAM-NEGATIVE BACTERIA | |
KANG | In vitro bacteriostatic test and time-kill curve of Qinyu burn gel |